US Broker Ratings

ImmunityBio, Inc. (IBRX) Stock Analysis: Unveiling a 231% Potential Upside in Biotech Innovation

As the healthcare sector continues to captivate investor interest, ImmunityBio, Inc. (NASDAQ: IBRX) stands out with a market cap of $3.04 billion and a compelling 231.40% potential upside. This biotechnology..

Concentra Group Holdings (CON): Investor Outlook Reveals 26.81% Upside Potential in Healthcare Sector

Concentra Group Holdings Parent, Inc. (CON) stands as a compelling player in the healthcare sector, specifically within the medical care facilities industry. Based in Addison, Texas, the company focuses on..

Haemonetics Corporation (HAE) Investor Outlook: Assessing a 27% Potential Upside and Robust Buy Ratings

Haemonetics Corporation (NYSE: HAE), a key player in the healthcare sector specializing in medical devices, presents a compelling investment case for individual investors. With a current market capitalization of $3.44..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Potential Upside of 21.78% Ignites Investor Interest

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) has been capturing the attention of investors with its recent performance in the biotechnology sector, particularly with an enticing potential upside of 21.78%. Based in..

Soleno Therapeutics, Inc. (SLNO): Investor Outlook with a 47% Potential Upside

Soleno Therapeutics, Inc. (NASDAQ: SLNO), a clinical-stage biopharmaceutical company, is capturing investor attention with its promising potential upside of 47%. As it stands, the company is dedicated to developing novel..

Ionis Pharmaceuticals (IONS) Stock Analysis: A 63% Potential Upside with Strong Buy Ratings

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a pioneering force in the biotechnology sector, presents an intriguing investment opportunity for those with an appetite for innovation-driven growth. With a market capitalization of..

Akero Therapeutics (AKRO) Stock Analysis: A 40% Potential Upside in the Biotechnology Sector

For investors keen on exploring opportunities within the biotechnology sector, Akero Therapeutics, Inc. (NASDAQ: AKRO) presents a compelling case. With a market capitalization of $4.33 billion, Akero is positioned at..

Investor Outlook: Rhythm Pharmaceuticals, Inc. (RYTM) Eyes a 22.47% Upside with Strong Buy Ratings

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is making waves in the biotechnology sector with its focus on rare neuroendocrine diseases. The company’s lead product, IMCIVREE (setmelanotide), is poised to tackle several..

Krystal Biotech, Inc. (KRYS): Investor Outlook on a Promising 49.85% Upside Potential

Krystal Biotech, Inc. (KRYS), a burgeoning player in the biotechnology sector, is steadily carving a niche for itself by focusing on genetic medicines designed to address diseases with significant unmet..

Alkermes plc (ALKS) Stock Analysis: Unlocking Potential with a 25.93% Upside

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector specializing in drug manufacturing, has recently attracted attention from investors due to a promising potential upside of 25.93%. With..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: A Biotech Powerhouse with 52.91% Potential Upside

BridgeBio Pharma, Inc. (BBIO), a prominent player in the healthcare sector, specifically in biotechnology, offers a fascinating investment opportunity with significant potential upside. With a market capitalization of $7.33 billion,..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Exploring a Promising 36.39% Upside Potential

Telix Pharmaceuticals Limited (TLX), a biopharmaceutical company based in North Melbourne, Australia, is capturing investor attention with its significant 36.39% potential upside. Operating primarily in the biotechnology sector, Telix specializes..

Glaukos Corporation (GKOS) Stock Analysis: Eyeing a 31.69% Potential Upside

Glaukos Corporation (NASDAQ: GKOS), a prominent player in the healthcare sector, is making waves with its innovative medical devices designed to treat a range of ophthalmic conditions. With a market..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: A Digital Healthcare Leader with Robust Revenue Growth

iRhythm Technologies, Inc. (NASDAQ: IRTC) has been making waves in the healthcare sector, particularly within the medical devices industry. Known for its cutting-edge cardiac monitoring technology, iRhythm has positioned itself..

Regencell Bioscience Holdings L (RGC): Investor Outlook on the Unique Growth Potential in Traditional Chinese Medicine

Regencell Bioscience Holdings Limited (RGC) presents an intriguing opportunity for investors looking to tap into the healthcare sector’s niche of Traditional Chinese Medicine (TCM). Headquartered in Causeway Bay, Hong Kong,..

TransMedics Group, Inc. (TMDX) Stock Analysis: Healthcare Pioneer with Robust Growth but Limited Upside

TransMedics Group, Inc. (NASDAQ: TMDX) is making waves in the healthcare sector with its cutting-edge medical devices designed to revolutionize organ transplant therapy. The company’s flagship offering, the Organ Care..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Biotech Innovator with 90% Revenue Growth and Strategic Focus on MS Treatment

TG Therapeutics, Inc. (NASDAQ: TGTX) has captured investor attention with its impressive 90.40% revenue growth and a strategic focus on developing treatments for B-cell mediated diseases. As a commercial-stage biopharmaceutical..

HealthEquity, Inc. (HQY) Investor Outlook: Strong Buy Ratings Signal Potential Upside

HealthEquity, Inc. (NASDAQ: HQY) is capturing the attention of investors with its robust position in the healthcare sector, specifically in the health information services industry. Based in Draper, Utah, the..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: Unlocking a 69.73% Upside Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, is drawing attention from investors with an enticing potential upside of 69.73%. Headquartered in Dublin, Ireland, this healthcare..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: A Promising 57% Upside in Healthcare Innovation

Inspire Medical Systems, Inc. (NASDAQ: INSP), a leading name in the healthcare sector, is making waves with its innovative approach to treating obstructive sleep apnea (OSA). Based in Golden Valley,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds